Veterinary Medicines

Synulox RTU suspension for injection for cattle, pigs, dogs and cats

Authorised
  • Amoxicillin
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
Synulox RTU инжекционна суспензия за говеда, свине, кучета и котки
Synulox RTU suspension for injection for cattle, pigs, dogs and cats
Active substance:
  • Amoxicillin
  • Potassium clavulanate
Target species:
  • Cattle
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Amoxicillin
    14.00
    percent weight/volume
    /
    1.00
    millilitre(s)
  • Potassium clavulanate
    3.50
    percent weight/volume
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        42
        day
      • Milk
        60
        hour
    • Pig
      • Meat and offal
        31
        day
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Available in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1619
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/03/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."